Activation of the MEK–S6 Pathway in High-Grade Ovarian Cancers
Applied Immunohistochemistry and Molecular Morphology- United States
doi 10.1097/pai.0b013e3181e53e1c
Full Text
Abstract
Available in
Date
December 1, 2010
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)